Intervention Review

Metformin monotherapy for type 2 diabetes mellitus

  1. Antonio Saenz1,*,
  2. Inmaculada Fernandez-Esteban2,
  3. Angel Mataix2,
  4. Monica Ausejo Segura3,
  5. Marta Roqué i Figuls4,
  6. David Moher5

Editorial Group: Cochrane Metabolic and Endocrine Disorders Group

Published Online: 30 SEP 2015

Assessed as up-to-date: 30 SEP 2003

DOI: 10.1002/14651858.CD002966.pub4


How to Cite

Saenz A, Fernandez-Esteban I, Mataix A, Ausejo Segura M, Roqué i Figuls M, Moher D. Metformin monotherapy for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2015, Issue 9. Art. No.: CD002966. DOI: 10.1002/14651858.CD002966.pub4.

Author Information

  1. 1

    INSALUD - Madrid, Centro de Salud Pozuelo 1, Pozuelo de Alarcón, Madrid, Spain

  2. 2

    Instituto Madrileño de la Salud, Area 11, Madrid, Madrid, Spain

  3. 3

    Servicio de Farmacia Atencion Frimaria, Madrid, Spain

  4. 4

    CIBER Epidemiología y Salud Pública (CIBERESP), Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Catalunya, Spain

  5. 5

    Ottawa Hospital Research Institute, Ottawa, ON, Canada

*Antonio Saenz, Centro de Salud Pozuelo 1, INSALUD - Madrid, Emisora s/n, Pozuelo de Alarcón, Madrid, 28224, Spain. asaenzcalvo@telefonica.net.

Publication History

  1. Publication Status: Withdrawn from publication for reasons stated in the review
  2. Published Online: 30 SEP 2015

SEARCH

 
Reason for Withdrawal

Since the last publication of this review multiple changes like new publications, methods and other standards make it necessary to withdraw this review and register a new title on the same topic. To view the published versions of this article, please click the 'Other versions' tab.